Le Lézard
Classified in: Transportation, Health
Subjects: CHI, CSR

Hyundai Hope On Wheels Awards $250,000 Research Grant To Nationwide Children's Hospital In Honor Of National Childhood Cancer Awareness Month


COLUMBUS, Ohio, Sept. 28, 2017 /PRNewswire/ -- Hyundai Hope On Wheels® will today present Nationwide Children's Hospital with a $250,000 Hyundai Scholar Hope Grant. The grant funds will support the research of Timothy Cripe, MD, PhD, principal investigator and division chief of Hematology/Oncology and BMT. Dr. Cripe's current research focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies. He was among the first in the country to launch clinical trials of attenuated oncolytic viruses in children.

Hyundai Hope On Wheels(R) Logo. (PRNewsFoto/Hyundai Hope On Wheels) (PRNewsfoto/Hyundai Hope On Wheels)

This award is part of the organization's efforts during National Childhood Cancer Awareness Month.  In September alone, Hope On Wheels will award 40 research grants totaling $8.5 million to institutions nationwide. This brings the organization's donation total to $130 million since Hyundai joined the fight against pediatric cancer in 1998. With this latest grant, Hope On Wheels has awarded more than $1.4 million to Nationwide Children's Hospital.

"September is a special time for all of us at Hyundai because it's National Childhood Cancer Awareness Month. It's a time when we honor the courageous children battling cancer while also funding the doctors and researchers that are working tirelessly to provide care and develop new treatments," said Scott Fink, chairman, Hyundai Hope On Wheels Board of Directors. "Throughout the month we will share stories of the brave children battling cancer through our campaign theme called 'Every Handprint Tells A Story' and invite the public to join our fight."

The $250,000 Hyundai Scholar Hope Grant will be officially presented to Dr. Cripe today, September 28, 2017 at 11 a.m. Doctors and researchers that receive a grant from Hope On Wheels are named Hyundai Scholars and are presented with a special lab coat.

During the event, Columbus-area children battling cancer will participate in the program's signature Handprint Ceremony, in which they'll dip their hands in paint and place their handprints on a white 2017 Hyundai Santa Fe. Their colorful handprints on the official Hope Vehicle represent their individual and collective journeys, hopes and dreams.

The Hope On Wheels September campaign theme is 'Every Handprint Tells A Story.' This theme recognizes that there are many stakeholders in the fight to end childhood cancer ? the child, family, doctors, nurses, caregivers and researchers. The public is encouraged to visit our website at HyundaiHopeOnWheels.org to view videos of child cancer fighters, learn about the work of Hope On Wheels-funded researchers or add a virtual handprint of support on the website. Supporters are also asked to join our movement to End Childhood Cancer and to share our stories on Facebook, Twitter and Instagram.

For more information about Hyundai Hope On Wheels and to view a complete list of this year's grant winners, please visit HyundaiHopeOnWheels.org/research. Follow us on Facebook, Twitter or Instagram at facebook.com/HyundaiHopeOnWheels, twitter.com/HopeOnWheels or instagram.com/HyundaiHopeOnWheels

HYUNDAI HOPE ON WHEELS

Hyundai Hope On Wheels® is a 501(c)(3) non-profit organization that is committed to finding a cure for childhood cancer. Launched in 1998, Hyundai Hope On Wheels provides grants to eligible institutions nationwide that are pursuing life-saving research and innovative treatments for the disease. Hyundai Hope On Wheels is one of the largest non-profit funders of pediatric cancer research in the country, and primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 835 U.S. dealers. Since its inception, Hyundai Hope On Wheels has awarded more than $130 million towards childhood cancer research in pursuit of a cure.

HYUNDAI MOTOR AMERICA

Hyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Company of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through 835 dealerships nationwide. All new Hyundai vehicles sold in the U.S. are covered by the Hyundai Assurance program, which includes a 5-year/60,000-mile fully-transferable new vehicle limited warranty, Hyundai's 10-year/100,000-mile powertrain limited warranty and five years of complimentary Roadside Assistance.

For more details on Hyundai Assurance, please visit www.HyundaiAssurance.com
Please visit our media website at www.hyundainews.com
Hyundai Motor America on Twitter | YouTube | Facebook

 

SOURCE Hyundai Hope On Wheels


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: